Dana-Farber's commitment to fight cancer with equal parts research and patient care is supported by a broad and deep array of resources. These resources are organized into a number of specialized departments and centers that have evolved over time in response to changes in perceived needs and the availability of new technologies.
The following list explains their functions and roles:
Department of Biostatistics and Computational BiologyThe Department of Biostatistics and Computational Biology is the home of researchers trained in quantitative sciences. Their mission is to advance cancer research and cancer treatment, both directly and by providing their expertise through collaboration.
Department of Cancer BiologyThe Department of Cancer Biology focuses on fundamental problems in biology of relevance to cancer.
Department of Cancer Immunology and AIDSThe Department of Cancer Immunology and AIDS investigates fundamental questions in the development and expression of immune responses in cancer and autoimmune disease, as well as acquired immunodeficiency syndrome (AIDS).
Department of Cellular Therapies Quality Assurance (CTQA)Dana-Farber Cancer Institute has a longstanding commitment to quality. As part of this commitment, we have a dedicated department to ensure the quality of stem cells and other cellular products used for patients.
Department of ImagingThe Department of Imaging provides state-of-the-art technologies for imaging-based research, diagnostics, and drug development.
Department of Medical OncologyThe Department of Medical Oncology seeks to gain insights that lead to the prevention of cancer and to improve diagnosis and treatment of adult patients with cancer. The Department engages in a broad range of basic and clinical research, patient care, and teaching.
Department of Pediatric OncologyThe Department of Pediatric Oncology is committed to promoting laboratory research, translational investigation, and clinical studies to better understand and treat childhood cancers.
Department of Psychosocial Oncology and Palliative CareIn 2008, Dana-Farber created the new Department of Psychosocial Oncology and Palliative Care. This was done in recognition of the growth and evolution of these fields and their centrality to cancer care.
Department of Radiation OncologyThe Department of Radiation Oncology is committed to combining advances in clinical and laboratory research with developments in radiation physics. The goal is to promote a better understanding of the biology of cancer and normal tissues and to improve the treatment of cancer.
Arthur and Linda Gelb Center for Translational ResearchThe Arthur and Linda Gelb Center for Translational Research provides a platform and support for investigators at Dana-Farber, collaborating institutions, and industry — to promote discoveries in the biology of genitourinary (GU) cancers, and to translate these findings into clinical benefit.
Blood Cancer Prevention of Progression Clinic (BCPC)The Blood Cancer Prevention of Progression Clinic (BCPC) is a research program focused on understanding the progression and clonal evolution of blood cancers – with an ultimate aim to develop targeted therapeutic agents that can eliminate the early clones of disease.
Blood Cancer Research PartnershipBlood Cancer Research Partnership (BCRP) provides innovative clinical trials to patients closer to their home. BCRP’s main objective is to bring the novel trials to the patients across the country.
Cancer Care Equity Program (CCEP)The CCEP was established to serve as a bridge between research and outreach efforts to address cancer disparities at Dana-Farber Cancer Institute.
The Center for AIDS ResearchThe Center for AIDS Research is a program shared with Harvard University. Its mission is to expand, promote, and facilitate collaborative, multidisciplinary activities in HIV/AIDS research, education, and training among CFAR members and associate members throughout Harvard University, in order to help end the AIDS pandemic.
The Center for Community-Based ResearchThe Center for Community-Based Research (CCBR) develops innovative ways to lower cancer risk by working with community groups and organizations. CCBR uses the power of the community to study the factors that play a role in improving the prevention, early detection, and treatment of cancer.
Center for Patient SafetyThe mission of the Center for Patient Safety is to reduce the burden of medical injury in cancer care. The Center has a special interest in understanding the role that patients and families can play, together with clinicians, in preventing medical errors.
Phyllis F. Cantor Center for Research in Nursing and Patient Care ServicesThe mission of the Cantor Center is to reduce the burden of cancer through scholarly inquiry and rigorous research. The focus of the Center's research is the patient/family experience of living with a predisposition to or diagnosis of cancer, as well as survivorship issues post-treatment.
Search by last name:
Browse directory of
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: